药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Pirbuterol
Pazufloxacin
The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Pazufloxacin.
Pirbuterol
Bilastine
The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Bilastine.
Pirbuterol
Difloxacin
The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Difloxacin.
Pirbuterol
Sarafloxacin
The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Sarafloxacin.
Pirbuterol
Phosmet
The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Phosmet.
Pirbuterol
Orbifloxacin
The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Orbifloxacin.
Pirbuterol
Famphur
The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Famphur.
Pirbuterol
Olodaterol
The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Olodaterol.
Pirbuterol
Flumequine
The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Flumequine.
Pirbuterol
Chlorcyclizine
The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Chlorcyclizine.
Pirbuterol
Eribulin
The risk or severity of QTc prolongation can be increased when Eribulin is combined with Mirabegron.
Pirbuterol
Geranylgeranyl diphosphate
The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Mirabegron.
Pirbuterol
Farnesyl diphosphate
The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Mirabegron.
Pirbuterol
Triptorelin
The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Mirabegron.
Pirbuterol
Histrelin
The risk or severity of QTc prolongation can be increased when Histrelin is combined with Mirabegron.
Pirbuterol
Buserelin
The risk or severity of QTc prolongation can be increased when Buserelin is combined with Mirabegron.
Pirbuterol
Degarelix
The risk or severity of QTc prolongation can be increased when Degarelix is combined with Mirabegron.
Pirbuterol
Pasireotide
The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Mirabegron.
Pirbuterol
Cariporide
The risk or severity of QTc prolongation can be increased when Cariporide is combined with Mirabegron.
Pirbuterol
Amisulpride
The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Mirabegron.